JP2023512843A5 - - Google Patents
Info
- Publication number
- JP2023512843A5 JP2023512843A5 JP2022548412A JP2022548412A JP2023512843A5 JP 2023512843 A5 JP2023512843 A5 JP 2023512843A5 JP 2022548412 A JP2022548412 A JP 2022548412A JP 2022548412 A JP2022548412 A JP 2022548412A JP 2023512843 A5 JP2023512843 A5 JP 2023512843A5
- Authority
- JP
- Japan
- Prior art keywords
- ivabradine
- amiodarone
- pharmaceutical product
- administration
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062972330P | 2020-02-10 | 2020-02-10 | |
| US62/972,330 | 2020-02-10 | ||
| PCT/US2021/017220 WO2021163037A1 (en) | 2020-02-10 | 2021-02-09 | Methods of treating and preventing engraftment arrhythmias |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023512843A JP2023512843A (ja) | 2023-03-29 |
| JP2023512843A5 true JP2023512843A5 (https=) | 2024-07-02 |
Family
ID=77291628
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022548412A Pending JP2023512843A (ja) | 2020-02-10 | 2021-02-09 | 移植後不整脈を治療および予防する方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230077983A1 (https=) |
| EP (1) | EP4103206A4 (https=) |
| JP (1) | JP2023512843A (https=) |
| KR (1) | KR20220140532A (https=) |
| CN (1) | CN115484966A (https=) |
| AU (1) | AU2021218653A1 (https=) |
| BR (1) | BR112022015768A2 (https=) |
| CA (1) | CA3166678A1 (https=) |
| IL (1) | IL295236A (https=) |
| MX (1) | MX2022009807A (https=) |
| WO (1) | WO2021163037A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3979997A1 (en) * | 2019-06-06 | 2022-04-13 | Novo Nordisk A/S | Application of antiarrhythmic agents to stem cell derived cardiomyocytes and uses thereof |
| US20230250393A1 (en) * | 2022-02-09 | 2023-08-10 | University Of Washington | Pre-treating cardiomyocytes with anti-arrhythmic drugs to reduce engraftment arrhythmia |
| WO2023173123A1 (en) * | 2022-03-11 | 2023-09-14 | Sana Biotechnology, Inc. | Genetically modified cells and compositions and uses thereof |
| EP4593821A2 (en) * | 2022-09-28 | 2025-08-06 | Bluerock Therapeutics LP | Compositions and methods for treating graft-related arrhythmia |
| WO2025137525A1 (en) * | 2023-12-22 | 2025-06-26 | Bluerock Therapeutics Lp | Molecular identification of cardiomyocytes for cardiac cell therapy |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG192305A1 (en) * | 2012-01-20 | 2013-08-30 | Singapore Health Serv Pte Ltd | Induced pluripotent stem cell (ipsc)-derived cardiomyocyte-like cells and uses thereof in screening for agents |
| US9994812B2 (en) * | 2012-04-04 | 2018-06-12 | University Of Washington Through Its Center For Commercialization | Systems and method for engineering muscle tissue |
| US9855317B2 (en) * | 2015-04-27 | 2018-01-02 | Reflex Medical, Inc. | Systems and methods for sympathetic cardiopulmonary neuromodulation |
| AU2018235964A1 (en) * | 2017-03-15 | 2019-08-15 | Cambridge Enterprise Limited | Methods and compositions for enhancing cardiomyocyte maturation and engraftment |
| EP3979997A1 (en) * | 2019-06-06 | 2022-04-13 | Novo Nordisk A/S | Application of antiarrhythmic agents to stem cell derived cardiomyocytes and uses thereof |
-
2021
- 2021-02-09 US US17/798,127 patent/US20230077983A1/en active Pending
- 2021-02-09 BR BR112022015768A patent/BR112022015768A2/pt not_active Application Discontinuation
- 2021-02-09 CN CN202180027573.1A patent/CN115484966A/zh active Pending
- 2021-02-09 CA CA3166678A patent/CA3166678A1/en active Pending
- 2021-02-09 MX MX2022009807A patent/MX2022009807A/es unknown
- 2021-02-09 JP JP2022548412A patent/JP2023512843A/ja active Pending
- 2021-02-09 IL IL295236A patent/IL295236A/en unknown
- 2021-02-09 KR KR1020227029054A patent/KR20220140532A/ko not_active Withdrawn
- 2021-02-09 EP EP21753964.2A patent/EP4103206A4/en active Pending
- 2021-02-09 AU AU2021218653A patent/AU2021218653A1/en not_active Abandoned
- 2021-02-09 WO PCT/US2021/017220 patent/WO2021163037A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023512843A5 (https=) | ||
| US10660880B2 (en) | Dosing regimen for a selective S1P1 agonist | |
| JP2011518785A (ja) | 心血管入院または死亡の予防に用いる薬剤を調製するためのドロネダロンの使用 | |
| WO2014082514A1 (zh) | 一种启动哺乳动物干细胞的方法及二氧化氯在制备用于启动哺乳动物干细胞的药物的应用 | |
| WO2021068802A1 (zh) | Nadh 及其盐和 / 或 nmn 在制备肌肉增强或抑制肌肉量下降的药物或保健品中的应用 | |
| CN112438976B (zh) | 一种具有肾脏保护作用的药物组合物 | |
| Wilting et al. | QTc prolongation and torsades de pointes in an elderly woman taking fluoxetine | |
| AU2017365926B2 (en) | Treatments for heart failure and cardiac ischaemic reperfusion injury | |
| CN107303390A (zh) | Dpp4抑制剂在制备治疗低氧性肺动脉高压药物中的用途 | |
| CN108721294A (zh) | 化合物epz5676及其相关抑制剂在制备治疗心肌纤维化疾病药物中的用途 | |
| US20250375405A1 (en) | N-lactoyl-phenylalanine for preventing and/or treating ischemic heart disease and method for preventing and/or treating ischemic heart disease | |
| WO2007048352B1 (en) | Pharmaceutical composition and method for regenerating myofibers in the treatment of muscle injuries | |
| CN119564692A (zh) | 利匹韦林在制备治疗心肌梗死药物中的应用 | |
| Hamid et al. | Effect of single dose magnesium on arrhythmias in patients undergoing coronary artery bypass surgery | |
| WO2023185085A1 (zh) | Pd1抑制剂在制备心脏成纤维细胞转分化抑制剂中的用途 | |
| CN103203009B (zh) | 一种五肽的部分代谢物用于制备抗心肌缺血产品的新用途 | |
| Resnekov et al. | Sustained-release quinidine (Kinidin Durules) in maintaining sinus rhythm after electroversion of atrial dysrhythmias | |
| CN105833001B (zh) | 参芪降糖颗粒在制备糖尿病性心脏病药物中的用途 | |
| Rampton | Hypertensive crisis in a patient given sinemet, metoclopramide, and amitriptyline | |
| WO2011141872A1 (en) | Use of dronedarone for the preparation of a medicament for use in the prevention of cardiovascular hospitalization or of mortality in patients having a first recurrence of atrial fibrillation or atrial flutter | |
| TWI629991B (zh) | 牛樟芝在防治心肌肥大及心肌纖維化中的應用 | |
| Chowdhury et al. | The SGLT2 inhibitor empagliflozin reduces mortality in experimental pulmonary hypertension | |
| RU2822010C1 (ru) | Способ терапии сердечно-сосудистого заболевания | |
| CN102085208B (zh) | 一种治疗冠心病、心绞痛的药物组合物 | |
| CN109364050A (zh) | 艾地苯醌在制备治疗肺动脉高压药物中的应用 |